Validations: Extensions, Changes & Re-verification
Interim Controls While Extensions Are Proven Interim Controls While Extensions Are Proven 1. Introduction In the pharmaceutical industry, rigorously validating processes and ensuring compliance with regulatory standards are paramount to delivering safe and effective medications. One of the crucial aspects of validation is understanding hold times, especially for equipment, bulk products, and intermediates. This guide delves into interim controls while…
Human Factors in Hold-Time Changes: Training & Roles Human Factors in Hold-Time Changes: Training & Roles Understanding Hold-Time Studies in Pharmaceutical Manufacturing Hold-time studies are critical in pharmaceutical manufacturing to ensure that products maintain their quality and comply with regulatory requirements during the periods when they are not actively processed. The concept of hold-time refers to the duration for which…
Risk–Benefit Narratives for Extensions Introduction to Risk–Benefit Narratives Understanding risk and benefit narratives is essential for pharmaceutical professionals engaged in hold-time studies. These narratives serve as the cornerstone for justifying extensions of equipment hold times, particularly for bulk and intermediate hold scenarios. Regulatory authorities such as the US FDA, EMA, and MHRA provide guidelines on acceptable microbial limits, bioburden trending,…
Adding New Products to Existing Hold Claims Adding New Products to Existing Hold Claims This article provides detailed guidance for adding new products to existing hold claims in the pharmaceutical industry. The main focus is on understanding equipment hold time, especially for bulk and intermediate holds, as well as establishing robust microbial limits, conducting endotoxin limit tests, and utilizing bioburden…
Seasonal/Environmental Changes: Revisiting Hold Claims Seasonal/Environmental Changes: Revisiting Hold Claims The pharmaceutical industry operates under stringent regulations, ensuring that products maintain quality and safety throughout their lifecycle. One critical aspect of this process is understanding hold times for both bulk materials and equipment. This article serves as a comprehensive tutorial on revisiting hold claims, addressing the implications of seasonal and…
Deviation Learnings as Triggers for Re-Work Deviation Learnings as Triggers for Re-Work Introduction to Equipment Hold Time Studies In the pharmaceutical industry, maintaining compliance with regulatory expectations around hold times is crucial for ensuring product quality and safety. Equipment hold time studies assess the validity of operational procedures relating to the storage of drugs or intermediate products, particularly concerning bulk…
Re-Verification Protocols: Smart, Fast, Defensible Re-Verification Protocols: Smart, Fast, Defensible Understanding Hold Time in Pharmaceutical Manufacturing In pharmaceutical manufacturing, understanding hold time for equipment, bulk products, and intermediates is essential for ensuring product quality and compliance with regulatory standards set forth by the FDA, EMA, MHRA, and PIC/S. Hold time refers to the maximum duration an item may remain in…
Bridging Data Across Sites: Bias and Parity Understanding Equipment Hold Time: Importance and Regulatory Context Equipment hold time is a critical consideration in pharmaceutical manufacturing, ensuring product integrity and compliance. Hold times refer to the period during which materials (both bulk drug substances and intermediates) can safely remain in production equipment without compromising quality. The regulatory landscape emphasizes the need…
Documentation Packages for Extension Requests Introduction to Extension Requests in Hold-Time Studies The pharmaceutical industry is governed by strict guidelines to ensure the quality and safety of medicinal products. Extensions related to hold-time studies—specifically for bulk and intermediate products—are particularly relevant in this context. Regulatory bodies such as the US FDA, EMA, and MHRA emphasize the importance of well-documented procedures…
Material/Component Changes: Impact on Hold-Time Material/Component Changes: Impact on Hold-Time In pharmaceutical manufacturing, maintaining the integrity and quality of products during hold times is crucial. This tutorial serves as a step-by-step guide aimed at providing pharmaceutical professionals with a comprehensive understanding of how material and component changes can impact hold-time studies, specifically concerning bulk, intermediate, and cleaning holds. This guide…